Skip to main content
. Author manuscript; available in PMC: 2018 Nov 2.
Published in final edited form as: Lancet Glob Health. 2018 Aug;6(8):e885–e893. doi: 10.1016/S2214-109X(18)30257-2

Figure 2: Absolute risk reduction for each intervention compared with the standard of care in (A) the East African region and (B) Colombia.

Figure 2:

Error bars are 95% uncertainty intervals. Percentages in brackets are the proportions of women who present with advanced-stage disease. ER=oestrogen-receptor. B=endocrine therapy for ER-positive cases. C=B plus chemotherapy for ER-negative cases. D=C plus chemotherapy for advanced ER-positive cases.